Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: A preliminary study

Anesthesiology

Volumn 112, Issue 4, 2010, Pages 926-935

  Paugam Burtz, Catherine ^a,b,c   Albuquerque, Miguel ^b   Baron, Gabriel ^c,d   Bert, Frederic ^a   Voitot, Hélène ^a   Delefosse, Didier ^a   Dondero, Federica ^a   Sommacale, Daniele ^a   Francoz, Claire ^a   Hanna, Nadine ^a   Belghiti, Jacques ^a   Ravaud, Philippe ^a   Bedossa, Pierre ^c,d,e   Mantz, Jean ^b   Paradis, Valérie ^a  

^a BEAUJON HOSPITAL   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d BICHAT HOSPITAL   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PLASMA PROTEIN; PROCALCITONIN; PROTEOME;

ABDOMINAL INFECTION; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; INTENSIVE CARE UNIT; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MORTALITY; ORGAN TRANSPLANTATION; PLASMA; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEOMICS; SEPSIS; SEPTIC SHOCK; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; URINARY TRACT INFECTION; VALIDATION STUDY;

EID: 77950865172     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181d049f0     Document Type: Article

References (47)

1. Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, O'Grady JG, Castaing D, Klempnauer J, Jamieson N, Neuhaus P, Lerut J, de Ville de Goyet J, Pollard S, Salizzoni M, Rogiers X, Muhlbacher F, Garcia Valdecasas JC, Broelsch C, Jaeck D, Berenguer J, Gonzalez EM, Adam R: 3-month and 12-month mortality after first liver transplant in adults in Europe: Predictive models for outcome. Lancet 2006; 367:225-232
2. Mueller AR, Platz KP, Kremer B: Early postoperative complications following liver transplantation. Best Pract Res Clin Gastroenterol 2004; 18:881-900
3. Bion J, Jaeschke R, Thompson BT, Levy M, Dellinger RP: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34:1163-1164
4. Marshall JC, Reinhart K: Biomarkers of sepsis. Crit Care Med 2009; 37:2290-2298
5. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med 2006; 34:1996-2003
6. Tang BM, Eslick GD, Craig JC, McLean AS: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: Systematic review and meta-analysis. Lancet Infect Dis 2007; 7:210-217
7. Eyraud D, Ben Ayed S, Tanguy ML, Vezinet C, Siksik JM, Bernard M, Fratea S, Movschin M, Vaillant JC, Coriat P, Hannoun L: Procalcitonin in liver transplantation: Are high levels due to donors or recipients? Crit Care 2008; 12:R85
8. Zazula R, Prucha M, Tyll T, Kieslichova E: Induction of procalcitonin in liver transplant patients treated with antithymocyte globulin. Crit Care 2007; 11:R131
9. Anderson L, Seilhamer J: A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997; 18:533-537
10. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359:572-577 (Pubitemid 34178440)
11. Paradis V, Degos F, Dargere D, Pham N, Belghiti J, Degott C, Janeau JL, Bezeaud A, Delforge D, Cubizolles M, Laurendeau I, Bedossa P: Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 2005; 41:40-47
12. Morra R, Munteanu M, Bedossa P, Dargere D, Janneau JL, Paradis V, Ratziu V, Charlotte F, Thibault V, Imbert-Bismut F, Poynard T: Diagnostic value of serum protein profiling by SELDI-TOF Proteinchip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C. Aliment Pharmacol Ther 2007; 26:847-858
13. Belghiti J, Noun R, Sauvanet A: Temporary portocaval anastomosis with preservation of caval flow during orthotopic liver transplantation. Am J Surg 1995; 169:277-279
14. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256 (Pubitemid 36444440)
15. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
16. Leone M, Garnier F, Avidan M, Martin C: Catheter-associated urinary tract infections in intensive care units. Microbes Infect 2004; 6:1026-1032
17. Timsit JF: Diagnosis and prevention of catheter-related infections. Curr Opin Crit Care 2007; 13:563-571
18. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
19. Sigdel TK, Sarwal MM: The proteogenomic path towards biomarker discovery. Pediatr Transplant 2008; 12:737-747
20. Trak-Smayra V, Dargere D, Noun R, Albuquerque M, Yaghi C, Gannage-Yared MH, Bedossa P, Paradis V: Serum proteomic profiling of obese patients: Correlation with liver pathology and evolution after bariatric surgery. Gut 2009; 58:825-832
21. Akobeng AK: Understanding diagnostic tests 2: Likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr 2007; 96:487-491
22. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69:89-95
23. Longrois D, Agavriloaia M, Devaux Y, Mertes PM: [Comments on methodological problems related to the use of biomarkers in clinical practice and research.] Ann Fr Anesth Reanim 2009; 28:473-481
24. Kurian S, Grigoryev Y, Head S, Campbell D, Mondala T, Salomon DR: Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers. Int Immunopharmacol 2007; 7:1948-1960
25. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596
26. Clec'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y: Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006; 34:102-107
27. Søreide K: Receiver-operating characteristic (ROC) curve analysis in diagnostic, prognostic and predictive biomarker research. J Clin Pathol 2009; 62:1-5
28. Gibot S, Kolopp-Sarda MN, Bene MC, Cravoisy A, Levy B, Faure GC, Bollaert PE: Plasma level of a triggering receptor expressed on myeloid cells-1: Its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004; 141:9-15
29. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and metaanalysis. Clin Infect Dis 2004; 39:206-217
30. Karvunidis T, Mares J, Thongboonkerd V, Matejovic M: Recent progress of proteomics in critical illness. Shock 2009; 31:545-552
31. Paradis V, Asselah T, Dargere D, Ripault MP, Martinot M, Boyer N, Valla D, Marcellin P, Bedossa P: Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin. Gastroenterology 2006; 130:2189-2197
32. Hodgetts A, Levin M, Kroll JS, Langford PR: Biomarker discovery in infectious diseases using SELDI. Future Microbiol 2007; 2:35-49
33. Grus FH, Podust VN, Bruns K, Lackner K, Fu S, Dalmasso EA, Wirthlin A, Pfeiffer N: SELDI-TOF-MS Proteinchip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci 2005; 46:863-876
34. Kalenka A, Feldmann RE Jr, Otero K, Maurer MH, Waschke KF, Fiedler F: Changes in the serum proteome of patients with sepsis and septic shock. Anesth Analg 2006; 103: 1522-1526
35. Baggerly KA, Morris JS, Coombes KR: Reproducibility of SELDITOF protein patterns in serum: Comparing datasets from different experiments. Bioinformatics 2004; 20:777-785
36. Service RF: Proteomics. Will biomarkers take off at last? Science 2008; 321:1760
37. Service RF: Proteomics. Proteomics ponders prime time. Science 2008; 321:1758-1761
38. Dijkstra M, Vonk RJ, Jansen RC: SELDI-TOF mass spectra: A view on sources of variation. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 847:12-23
39. Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, Berchuck A, Van Haaften-Day C, Hacker NF, de Bruijn HW, van der Zee AG, Jacobs IJ, Fung ET, Chan DW: Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 2004; 64:5882-5890
40. Kasthuri RS, Wroblewski M, Jilma B, Key NS, Nelsestuen GL: Potential biomarkers of an exaggerated response to endotoxemia. Biomarkers 2007; 12:287-302
41. Lorenz E, Mira JP, Frees KL, Schwartz DA: Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002; 162:1028-1032
42. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riche F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF: Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study. JAMA 1999; 282:561-568
43. Nuijens JH, Eerenberg-Belmer AJ, Huijbregts CC, Schreuder WO, Felt-Bersma RJ, Abbink JJ, Thijs LG, Hack CE: Proteolytic inactivation of plasma C1- inhibitor in sepsis. J Clin Invest 1989; 84:443-450
44. Ozier Y, Klinck JR: Anesthetic management of hepatic transplantation. Curr Opin Anaesthesiol 2008; 21:391-400
45. de Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Hendriks HG, Slooff MJ, Porte RJ: The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008; 106:32-44
46. Fishman JA: Infection in solid-organ transplant recipients. N Engl J Med 2007; 357:2601-2614
47. Fenollar F, Goncalves A, Esterni B, Azza S, Habib G, Borg JP, Raoult D: A serum protein signature with high diagnostic value in bacterial endocarditis: Results from a study based on surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. J Infect Dis 2006; 194:1356-1366